Drugs / [89Zr]Zr-crefmirlimab berdoxam
[89Zr]Zr-crefmirlimab berdoxam
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT06218069 Comparator | Feb → Dec 2025 overdue | non-small cell lung carcinoma | Radboud University Medical Center | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | [89Zr]Zr-crefmirlimab berdoxam | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06218069 ↗ |
| Modality | Diagnostic / imaging agent | “radiolabeled imaging tracer” NCT06218069 ↗ |
| Route | Intravenous | “administered via an intravenous catheter” NCT06218069 ↗ |